Latest Regulatory News

New Frontier Minerals accelerates its NWQ Copper Project development by sending bulk samples to Austral Resources’ Mt Kelly plant, formalizing a key processing partnership that could fast-track copper output.

Xanadu Mines Limited has received a conditional off-market takeover offer from Bastion Mining Pte Ltd at A$0.08 per share, representing a significant premium. The company’s independent Takeover Committee unanimously recommends acceptance, supported by an independent expert’s fair and reasonable valuation.

MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.

REA Group has confirmed it is under investigation by the ACCC concerning its subscription offerings, signaling potential regulatory scrutiny for the property tech giant.

Bastion Mining has tabled a recommended $0.08 per share cash offer for Xanadu Mines, representing a significant premium and backed unanimously by Xanadu's independent directors and largest shareholder.

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.

Neuren Pharmaceuticals posted record 2024 financials driven by DAYBUE royalties and advanced NNZ-2591 into Phase 3 trials, while launching a $50 million share buy-back amid volatile market sentiment.

TerraCom Limited has reached a significant settlement with ASIC to resolve whistleblower-related civil proceedings, agreeing to pay $8.5 million pending Federal Court approval.

Beacon Minerals has secured an option agreement to acquire the Wealth of Nations gold tenements near its Jaurdi processing plant, setting the stage for renewed exploration and potential resource growth.

Piche Resources has received formal environmental approval to begin its maiden drilling campaign at the Cerro Chacon gold-silver project in Argentina, targeting a 14 km mineralised corridor with 57 planned drill holes.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

Prescient Therapeutics has reached a pivotal milestone by dosing the first patient in its Phase 2a clinical trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma (CTCL), aiming to evaluate safety and efficacy across multiple international sites.